Cresset Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5K | Hold |
22,955
| – | – | ﹤0.01% | 1614 |
|
|
2025
Q1 | $27.1K | Sell |
22,955
-2,928
| -11% | -$3.46K | ﹤0.01% | 1630 |
|
|
2024
Q4 | $47.4K | Sell |
25,883
-40,890
| -61% | -$74.8K | ﹤0.01% | 1621 |
|
|
2024
Q3 | $114K | Sell |
66,773
-2,280
| -3% | -$3.88K | ﹤0.01% | 1998 |
|
|
2024
Q2 | $94.6K | Sell |
69,053
-9,857
| -12% | -$13.5K | ﹤0.01% | 1915 |
|
|
2024
Q1 | $296K | Buy |
78,910
+15,688
| +25% | +$58.8K | ﹤0.01% | 1573 |
|
|
2023
Q4 | $620K | Buy |
63,222
+6,153
| +11% | +$60.4K | ﹤0.01% | 1093 |
|
|
2023
Q3 | $477K | Buy |
57,069
+6,125
| +12% | +$51.1K | ﹤0.01% | 1172 |
|
|
2023
Q2 | $678K | Buy |
+50,944
| New | +$678K | ﹤0.01% | 987 |
|
|
2022
Q4 | – | Sell |
-48,405
| Closed | -$281K | – | 843 |
|
|
2022
Q3 | $281K | Sell |
48,405
-339
| -0.7% | -$1.97K | ﹤0.01% | 688 |
|
|
2022
Q2 | $214K | Buy |
48,744
+687
| +1% | +$3.02K | ﹤0.01% | 821 |
|
|
2022
Q1 | $437K | Sell |
48,057
-2,932
| -6% | -$26.7K | ﹤0.01% | 641 |
|
|
2021
Q4 | $1.04M | Sell |
50,989
-16,118
| -24% | -$330K | 0.01% | 442 |
|
|
2021
Q3 | $1.72M | Buy |
67,107
+250
| +0.4% | +$6.39K | 0.02% | 256 |
|
|
2021
Q2 | $2.34M | Buy |
66,857
+524
| +0.8% | +$18.3K | 0.03% | 181 |
|
|
2021
Q1 | $2.21M | Buy |
+66,333
| New | +$2.21M | 0.04% | 166 |
|
|
2020
Q4 | – | Sell |
-32,000
| Closed | -$316K | – | 796 |
|
|
2020
Q3 | $316K | Buy |
+32,000
| New | +$316K | 0.01% | 494 |
|